- Home
- CAG vs CAI Comparison
CAG vs CAI Comparison
Compare CAG & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAG
- CAI
- Stock Information
- Founded
- CAG 1919
- CAI 2008
- Country
- CAG United States
- CAI United States
- Employees
- CAG N/A
- CAI N/A
- Industry
- CAG Packaged Foods
- CAI Medical Specialities
- Sector
- CAG Consumer Staples
- CAI Health Care
- Exchange
- CAG Nasdaq
- CAI Nasdaq
- Market Cap
- CAG 9.3B
- CAI 8.9B
- IPO Year
- CAG N/A
- CAI 2025
- Fundamental
- Price
- CAG $17.16
- CAI $29.72
- Analyst Decision
- CAG Hold
- CAI Strong Buy
- Analyst Count
- CAG 11
- CAI 6
- Target Price
- CAG $21.64
- CAI $35.50
- AVG Volume (30 Days)
- CAG 11.3M
- CAI 620.6K
- Earning Date
- CAG 12-18-2025
- CAI 11-05-2025
- Dividend Yield
- CAG 8.05%
- CAI N/A
- EPS Growth
- CAG 73.36
- CAI N/A
- EPS
- CAG 1.77
- CAI N/A
- Revenue
- CAG $11,450,500,000.00
- CAI $533,847,000.00
- Revenue This Year
- CAG N/A
- CAI $64.66
- Revenue Next Year
- CAG N/A
- CAI $45.81
- P/E Ratio
- CAG $9.82
- CAI N/A
- Revenue Growth
- CAG N/A
- CAI 106.53
- 52 Week Low
- CAG $17.35
- CAI $25.40
- 52 Week High
- CAG $29.86
- CAI $42.50
- Technical
- Relative Strength Index (RSI)
- CAG 31.89
- CAI N/A
- Support Level
- CAG $18.26
- CAI N/A
- Resistance Level
- CAG $18.99
- CAI N/A
- Average True Range (ATR)
- CAG 0.39
- CAI 0.00
- MACD
- CAG -0.12
- CAI 0.00
- Stochastic Oscillator
- CAG 9.43
- CAI 0.00
About CAG ConAgra Brands Inc.
Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, Wish-Bone, and Chef Boyardee. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.
About CAI Caris Life Sciences Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.